Individualized yoga for inpatient children undergoing intensive chemotherapy feasible
the ONA take:
As in adult patients with cancer, fatigue is an important problem for pediatric patients with cancer. Yoga may be an equally effective intervention for these patients.
Researchers from the Hospital for Sick Children, in Toronto, Ontario, Canada, conducted a randomized controlled trial to determine the feasibility of individualized yoga for hospitalized children receiving intensive chemotherapy. Feasibility was defined as the ability to deliver at least 60% of the planned three times weekly yoga sessions for at least 70% of the participants.
The trial included 11 patients, ages 7 to 18 years, who had acute myeloid lymphoma (AML) or were undergoing haematopoetic stem cell transplantation (HSCT). The primary objective was to determine feasibility of yoga intervention in this patient population; secondary objectives included fatigue and quality of life (QoL) for the child via parent/guardian proxy-report, self-report parent QoL, and self-report child assessment.
The researchers found 10 of the patients were able to participate in the yoga sessions. Qualitative feedback from both the children and their parents indicated physical and psychological benefits were achieved.
The researchers concluded that individualized yoga is feasible for children receiving intensive chemotherapy. They also found measuring its benefits on fatigue and QoL is feasible provided parents are the primary respondents.
Individualized yoga is feasible for children receiving intensive chemotherapy.
Sign Up for Free e-newsletters
- Leukemia Risk in Children, Maternal Use of Hormonal Contraception Linked in Population Study
- Hodgkin Lymphoma Survivorship Marked by Periods of Actionable Distress
- Medication, Vaccination Uptake Improved by Involving Pharmacists in Elder Cancer Care
- Molecular Features May Predict Response in Primary Pancreatic Cancer
- Stem Cell Transplantation Superior to Chemotherapy for Relapsed/Refractory DLBCL, Follicular Lymphoma
- Navigating Prostate Cancer: A Patient's Experience From Diagnosis to Survivor
- Cell Phones and Cancer Risk (Fact Sheet)
- How Likely Are Oncologists to Refer for Palliative Care? Depends on Their Age
- Use of Corticosteroids With PD-1 or PD-L1 Inhibitors Associated With Poorer Outcomes in NSCLC
- Chemoimmunotherapy Increases Survival in Triple-Negative Breast Cancer
- Integrative Medicine in Childhood Cancer: Practices That Can Help Pediatric Patients
- Clinical Characteristics That Increase Risk of Chemotherapy-Induced Febrile Neutropenia Identified
- Dose-Escalation Mitigates Risk of Grade 3/4 Adverse Events With Ruxolitinib for Myelofibrosis
- Counseling Patients on Oral Chemotherapy
- Patients and Caregivers Worry About Cost of Cancer Care
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|